Receives two 483 observations
Alkem Laboratories announced that US FDA had conducted an inspection at the Company's manufacturing facility located at Baddi, India from 11 September, 2017 to 15 September, 2017. The Company has received the inspection report which contains two 483 observations.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
